Gadoversetamide | API DMFs | US Drug Master File (DMF) Details | Pharmacompass.com

Please Wait

Applying Filters...

Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

Data Compilation
#PharmaFlow

Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

Stock Recap
#PipelineProspector

Gadoversetamide

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 USDMF

FINISHED DOSAGE FORMULATIONS

25 FDF Dossiers, 9 FDA Orange Book, 16 Europe

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 1654.5MG/5ML (330.9MG/ML), INJECTABLE;INJECTION - 3309MG/10ML (330.9MG/ML), INJECTABLE;INJECTION - 4963.5MG/15ML (330.9MG/ML), INJECTABLE;INJECTION - 6618MG/20ML (330.9MG/ML), INJECTABLE;INJECTION - 16.545GM/50ML (330.9MG/ML), INJECTABLE;INJECTION - 3309MG/10ML (330.9MG/ML), INJECTABLE;INJECTION - 4963.5MG/15ML (330.9MG/ML), INJECTABLE;INJECTION - 6618MG/20ML (330.9MG/ML), INJECTABLE;INJECTION - 9927MG/30ML (330.9MG/ML)

RELATED EXCIPIENT COMPANIES

2 Actylis, 1 Finar, 1 Microlex e.U

EXCIPIENTS BY APPLICATIONS

3 Parenteral, 1 Fillers, Diluents & Binders

DIGITAL CONTENT

2 NEWS #PharmaBuzz

2 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

14 Finished Drug Prices

14 Finished Drug Prices

MARKET PLACE

2 APIs

2 APIs

REF. STANDARDS & IMPURITIES

2 USP, 1 Others

Xls download

Filters

List of Suppliers

Product Main Page

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/10/2024	Mallinckrodt Pharmaceuticals	Ireland	MALLINCKRODT INC	17360	OPTIMARK(R) (GADOVERSETAMIDE INJECTION) PARAMETRIC RELEASE	2004-06-23	Inactive	II	N/A

Contact us
to update this info